Next to unraveling the humane genome, understanding the relevant law may be the most complex part of life sciences work. We help bring clarity by explaining your legal options in plain language.
The life sciences sector faces a broad spectrum of complex and constantly evolving legal issues. To offer the highest quality legal advice in this area requires specialized and devoted representation. At Perley-Robertson, Hill & McDougall, we have a depth of technical, legal and business expertise advising start-up, early stage and mature companies in the biotech, bio-pharmaceutical, photonics, convergence, pharmacogenomics, ag-biotech, animal health and environmental sectors.
We work with research institutions including those associated with hospitals, government agencies and universities, corporate research operations, and technology transfer offices, as well as the venture capital and investment banking communities.
By drawing together a multi-disciplinary life sciences team from a number of practice areas including finance, corporate and commercial law, mergers and acquisitions, tax law and litigation, we can provide guidance and advice in a wide range of areas, including:
- Access to research grants from governments and private funding agencies
- Intellectual property, including developing and implementing intellectual property protection strategies, preparing and filing patents, and managing an intellectual property portfolio
- Competition law and international trade
- Federal and provincial regulatory compliance
- The Food and Drug Act
- Online sales
- Marketing and price controls
- Public policy
- Negotiating and structuring licensing arrangements and strategic alliances
- Performing due diligence activities
- Providing strategic advice on emerging legal issues and bioethics
- Representing companies and investors in financing transactions
- Resolving disputes